Company news
Shanghai Opm Biosciences Co., Ltd. Class A (SSE:688293) news
Shanghai Opm Biosciences Co., Ltd. Class A news releases on 6ix. Latest, Nov 29, 2025: Announcement on the Draft Revision of the Report (Draft) (Revised…
Press releases — page 2
Announcement on the Draft Revision of the Report (Draft) (Revised Edition) on Issuing Shares, Paying Cash for Asset Acquisition, Raising Supporting Funds
November 28, 2025
Announcement on Revision to Report Draft on Issuing Shares to Purchase Assets in Cash and Raise Supporting Funds
November 25, 2025
Announcement on Resolutions of the 16th Meeting of the 2nd Board of Supervisors
November 14, 2025
Announcement on Resolutions of the 16th Meeting of the 2nd Board of Directors
November 10, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 29, 2025
Announcement on the 1st Vesting Result of the 2nd Vesting Period of Those Initially Granted and the 1st Vesting Period of Those Reserved for Grant in 2023 Restricted Stock Incentive Plan and Listing of Shares
October 17, 2025
Announcement on Voluntary Disclosure of Wholly-owned Subsidiary's Successful Passage of EU QP Audit
September 26, 2025
Announcement on Resolutions of the 13th Meeting of the 2nd Board of Supervisors
September 24, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 19, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 8, 2025
Indicative Announcement on Reply to Regulatory Inquiry Regarding the Issuance of Shares and Cash Payment for Asset Acquisition with Supporting Fund-raising
September 3, 2025
Announcement on Resolutions of the 11th Meeting of the 2nd Board of Supervisors
September 1, 2025